Obeda
VialAarsh Biocare Pvt. Ltd.
- Strength Plan
- 1mg weekly protocol
- Est. Monthly Price
- ₹1,790
- Availability
- Metro + online resellers
2026 India GLP-1 Intelligence
Built for high-intent searches like semaglutide vs liraglutide, best generic brand India, and GLP-1 cost. Start with tools first, then connect on WhatsApp.
Independent research · Powered by WeightWonder
Molecule Comparison
| Molecule | Dosing | Weight Loss % | Cost | Availability | Patent | Muscle Risk |
|---|---|---|---|---|---|---|
SemaglutideBest Value | Weekly (after titration) | 12-17% | ₹1,600-₹4,200/mo | High in metro + tier-2 channels | Core molecule off-patent in India; device-level protections may vary | Moderate if protein + resistance training are not structured |
Liraglutide | Daily | 6-10% | ₹2,600-₹5,500/mo | Moderate, stronger in established chains | Older molecule landscape; branded device formats remain premium | Moderate due to daily adherence variability |
Tirzepatide | Weekly | 15-22% | ₹5,500-₹12,500/mo | Lower coverage; mostly specialist-led access | Newer molecule with active patent constraints | Moderate-high with aggressive calorie deficits |
Generic Brands
Aarsh Biocare Pvt. Ltd.
Natrax Therapeutics
FullLife Biopharma
NovelTreat Labs
Trinity Medilabs
GlenPeak Innovations
Glynova Lifesciences
Mashema Remedies
Bolic Healthcare
SizeWell Pharma
GLP-1 Cost Calculator
Monthly medication cost
₹1,850
Total for 3 months
₹5,550
WW GLP-1 Care comparison
Medication-only is ₹15,150 lower
WW benchmark uses ₹6,900/month inclusive-care baseline.
Hidden costs of unsupervised use
Medication-only plans often miss follow-up expenses. True monthly exposure estimate: ₹3,550/mo.
Baseline + follow-up labs
₹1,500-₹3,500
Often needed for glucose, thyroid, liver markers, and dose safety checks.
Doctor + nutrition reviews
₹800-₹2,000/mo
Without follow-up, dosing mistakes and rebound risk rise significantly.
Side-effect downtime
1-2 lost workdays/mo
Nausea/dehydration episodes can add recovery cost in unsupervised setups.
Risk Callout
Price-only choices can look smart in month one, then become expensive through side effects, drop-offs, and restarts.
31%
Reported stop within 90 days
Common reasons: nausea, dosing confusion, and low supervision.
2.1x
Higher rebound risk
Seen when medication is discontinued without maintenance planning.
₹8K+
Average avoidable spend
From mismatched formats, fake stock, or frequent restarts.
Methods Comparison
| Method | Typical Cost (12 months) | Expected Loss | Monitoring | Honest Cons |
|---|---|---|---|---|
| Unsupervised GLP-1 | ₹2.2L - ₹4.1L | 5-12% | Low | High dropout, dosing inconsistency, and fake-stock exposure |
| Crash Diets | ₹10K - ₹45K | 3-8% (short-term) | Low | Muscle loss and rebound are common |
| Online Plans | ₹25K - ₹80K | 4-10% | Medium | Often generic meal plans, limited medical personalization |
| Bariatric Surgery | ₹2.8L - ₹6.5L | 20-35% | High | Surgical risk, recovery time, and higher upfront spend |
| WW GLP-1 Care | ₹1.5L - ₹2.7L | 15-25% | High | Requires long-term adherence and program engagement |
Supervised Outcomes
15-25%
Typical supervised weight-loss range
90%
Program adherence at key follow-up milestones
₹40K+
Potential saving vs fragmented trial-and-error
FAQ
There is no single best brand for everyone. Match the brand to your dose, format preference, supply reliability, and verified source. Use the brand filter and cost calculator first, then confirm batch authenticity.
Vials are usually lower-cost but require precise handling. Pens are easier and faster for routine use but often cost more. The right choice depends on your comfort, supervision, and monthly budget.
Verify manufacturer details, batch number, expiry, cold-chain handling, and GST invoice. Avoid sources that cannot provide traceable procurement records.
For some users, tirzepatide may drive stronger loss outcomes, but cost and availability are much higher. Compare 6-12 month total cost and adherence feasibility before choosing.
It includes physician oversight, dose progression tracking, nutrition guidance, and follow-up planning. It is listed as one structured option in this neutral comparison.
Start with baseline labs, a medical review, and a monitored titration plan. Avoid self-escalation without follow-up, especially in the first 8-12 weeks.
Limited Weekly Intake Slots
If you are comparing options this week, act before dosage-support queues reset.
Use your tool results as input, then continue on WhatsApp or send your requirements for a detailed callback.